Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
902
-
Total 13F shares, excl. options
-
89.4M
-
Shares change
-
-700K
-
Total reported value, excl. options
-
$42.2B
-
Value change
-
-$353M
-
Put/Call ratio
-
1.58
-
Number of buys
-
493
-
Number of sells
-
-386
-
Price
-
$473.14
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2021
1,077 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 902 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.4M shares
of 105M outstanding shares and own 85.12% of the company stock.
Largest 10 shareholders include FMR LLC (10.9M shares), BlackRock Inc. (9.65M shares), VANGUARD GROUP INC (8M shares), Capital World Investors (6.18M shares), STATE STREET CORP (4.55M shares), WELLINGTON MANAGEMENT GROUP LLP (3.88M shares), JPMORGAN CHASE & CO (3.04M shares), LOOMIS SAYLES & CO L P (2.88M shares), ALLIANCEBERNSTEIN L.P. (2.08M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.61M shares).
This table shows the top 902 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.